RPCEC00000358招募中未知
Assessment of the impact of Biomodulina T at the conclusion of first-line chemotherapy in patients diagnosed with non-small cell lung cancer, on the proportion of CD4+ T cells and terminally differentiated CD8+CD28 T cells, as well as the evaluation of these cell populations as possible biomarkers of the CIMAvax-EGF vaccine efficacy - BT- CIMAvax-EGF-NSCLC
Center of Molecular Immunology (CIM)0 个研究点开始时间: 2021年3月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- N/a: Single Arm Study. Masking: Open. Control Group: Uncontrolled. Assignment: Single Group. Purpose: Treatment
入排标准
- 年龄范围
- 18 years 至 one（—）
- 性别
- All
入选标准
- •1. Patients of any sex and age over or equal to 18 years old.
- •2. Patients diagnosed with cyto/histological carcinoma of non-small lung cells in all stages IIIb and IV
- •3. Patients who have signed informed consent for research
- •4. Patients with clinical status criteria (ECOG) from 0 to 2
排除标准
- •1. Patients of childbearing potential who are not using an appropriate method of contraception (intrauterine devices, hormonal contraceptives, barrier methods or tubal ligation). In case of male sex (vasectomy, condom use) for the duration of treatment.
- •2. Pregnant, lactating or post-breastfeeding patients.
研究者
相似试验
尚未招募
不适用
Biomodulina T in pediatric septic shock. Exploratory studySystemic Inflammatory Response SyndromeShock, SepticShockPathologic ProcessesPediatricsSeptic shockSepsisRPCEC00000327Centro Nacional de Biopreparados (BioCen)60
招募中
不适用
Biomodulin T-IM-oncological adults post chemotherapy-prevention COVID-19. Exploratory studyCOVID-19SARS-CoV2Coronavirus InfectionsSARS VirusCoronaviridae InfectionsBetacoronavirusDisease PreventionAgingRPCEC00000348ational Center for Bioproducts (BioCen).60
招募中
不适用
BIOMODULINA T in a long-lived population at high risk of COVID-19 infectioCOVID-19 preventionCOVID-19SARS-CoV2Disease PreventionAgingCoronavirus InfectionsSARS VirusCoronaviridae InfectionsBetacoronavirusRPCEC00000335Centro Nacional de Biopreparados (BioCen)
招募中
2 期
Evaluation of Biomodulin T® in patients with HIV/AIDS. Phase II/III.HIV InfectionsHuman Immunodeficiency VirusHIVLentiviruses InfectionsRetroviridae InfectionsRNA Viruses InfectionsSexually Transmitted Diseases, ViralImmunologic Deficiency SyndromesImmune System DiseasesEnvironmental IllnessVirus DiseasesSexually Transmitted DiseasesRPCEC00000288ational Center of Bioproducts (BIOCEN)198
招募中
3 期
Biomodulin T Intramuscular for Thymus Hypoplasia in Children. Phase IIIThymus hypoplasiaThymic HypoplasiaThymus Gland /abnormalitiesRPCEC00000247Center National of Bioproducts (BioCen)60